Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangosteen extract antimicrobial gauze pad vs 2% mupirocin ointment in pediatric superficial bacterial skin infections
TCTR20180828003Phase 2Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Sep 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mangosteen extract, mupirocin in skin and soft tissue infections (SSTIs), sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
mangosteen extractmupirocin
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on TCTR20180828003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180828003.